The many faces of host responses to tuberculosis

Immunology

Volumn 103, Issue 1, 2001, Pages 1-9

  Collins, Helen L ^a   Kaufmann, Stefan H E ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CELL RECEPTOR; CYTOKINE; GAMMA INTERFERON; GLYCOLIPID; LIPOARABINOMANNAN; MYCOLIC ACID;

CELL SURFACE; HOST CELL; HUMAN; IMMUNE RESPONSE; MACROPHAGE; MYCOBACTERIUM; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUBERCULOSIS;

ANIMALS; HUMANS; INTERFERON TYPE II; MACROPHAGES; MICE; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS;

EID: 0035016754     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2001.01236.x     Document Type: Review

References (77)

1. Ernst JD. Macrophage receptors for Mycobacterium tuberculosis. Infect Immun 1998; 66:1277-81.
2. Ehlers MW, Daffe M. Interactions between Mycobacterium tuberculosis and host cells: are mycobacterial sugars the key? Trends Microbiol 1998; 6:328-35.
3. Armstrong JA, Hart PD, Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J Exp Med 1975; 142:1-16.
4. Le Cabec V, Cols C, Maridonneau-Parini I. Nonopsonic phagocytosis of zymosan and Mycobacterium kansasii by CR3 (CD11b/CD18) involves distinct molecular determinants and is or is not coupled with NADPH oxidase activation. Infect Immun 2000; 68:4736-45.
5. Sturgill-Koszycki S, Schaible UE, Russell DG, Mycobacterium-containing phagosomes are accessible to early endosomes and reflect a transitional state in normal phagosome biogenesis. EMBO J 1996; 15:6960-8.
6. Schorey JS, Carroll MC, Brown EJ. A macrophage invasion mechanism of pathogenic mycobacteria. Science 1997; 277:1091-3.
7. Hu C, Mayadas-Norton T, Tanaka K, Chan J, Salgame P. Mycobacterium tuberculosis infection in complement receptor 3 deficient mice. J Immunol 2000; 165:2596-602.
8. Gatfield J, Pieters J. Essential role for cholesterol in entry of mycobacteria into macrophages. Science 2000; 288:1647-50.
9. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. The dorsoventral regulatory gene cassette Spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996; 86:973-80.
10. Qureshi ST, Larivier L, Leveque G, Clermont S, Moore KJ, Gros P, Malo D. Endotoxin tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 1999; 189:615-20.
11. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999; 163:3920-7.
12. Brightbill HD, Libraty DH, Krutzik SR, et al. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 1999; 285:732-9.
13. Underhill DM, Hajjar AM, Stevens A, Wilson CB, Bassetti M, Aderem A. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates against pathogens. Nature 1999; 401:811-15.
14. Russell DG, Dant J, Sturgill-Koszycki S. Mycobacterium avium- and Mycobacterium tuberculosis-containing vacuoles are dynamic, fusion-competent vesicles that are accessible to glycosphingolipids from the host cell plasmalemma. J Immunol 1996; 156:4764-73.
15. Gobin J, Horwitz MA. Exochelins of Mycobacterium tuberculosis remove iron from human iron-binding proteins and donate iron to mycobactins in the M. tuberculosis cell wall. J Exp Med 1996; 183:1527-32.
16. Olakanmi O, Britigan BE, Schlesinger LS. Gallium disrupts iron metabolism of mycobacteria residing within human macrophages. Infect Immun 2000; 68:5619-27.
17. De Voss JJ, Rutter K, Schroeder BG, Su H, Zhu Y, Barry CE, 3rd. The salicylate derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages. Proc Natl Acad Sci USA 2000; 97:1252-7.
18. Moyo VM, Gangaidzo IT, Gordeuk VR, Kiire CF, Macphail AP. Tuberculosis and iron overload in Africa: a review. Cent Afr J Med 1997; 43:334-19.
19. Höner zu Bentrup K, Miczak A, Swenson DL, Russell DG. Characterisation of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis. J Bacteriol 1999; 181:7161-7.
20. McKinney JD, Höner zu Bentrup K, Munoz-Elias EJ, et al. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 2000; 406:735-8.
21. MacMicking JD, Nathan C, Hom G, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995; 81:641-50.
22. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 1997; 94:5243-8.
23. -/-) mice. Infect Immun 2000; 68:1231-4.
24. Mastroeni P, Vazquez-Torres A, Fang FC, Xu Y, Khan S, Hormaeche CE, Dougan G. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J Exp Med 2000; 192:237-48.
25. Jagannath C, Actor JK, Hunter RL Jr. Induction of nitric oxide in human monocytes and monocyte cell lines by Mycobacterium tuberculosis. Nitric Oxide 1998; 2:174-8.
26. Rich EA, Torres M, Sada E, Finegan CK, Hamilton BD, Toossi Z, Mycobacterium tuberculosis (MTB) -stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB. Tuber Lung Dis 1997; 78:247-55.
27. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993; 178:2243-7.
28. Cooper AM, Magram J, Ferrante J, Orme IM. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 1997; 186:39-45.
29. Ottenhoff TM, Kumararatne D, Casanova J-L. Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular bacteria. Immunol Today 1998; 19:491-4.
30. Aung H, Toossi Z, McKenna SM, Gogate P, Sierra J, Sada E, Rich EA. Expression of TGFβ but not TNFα, IFNγ and IL-4 in granulomatous lung lesions in tuberculosis. Tuber Lung Dis 2000; 80:61-7.
31. Fenhalls G, Wong A, Bezuidenhout J, van Helden P, Bardin P, Lukey PT. In situ production of gamma interferon, interleukin 4 and tumor necrosis factor alpha mRNA in human lung tuberculous granulomas. Infect Immun 2000; 68:2827-36.
32. Moreira AL, Tsenova L, Murray PJ, Freeman S, Bergtold A, Chiriboga L, Kaplan G. Aerosol infection of mice with recombinant BCG secreting murine IFNγ partially reconstitutes local protective immunity. Microb Pathogen 2000; 29:175-85.
33. Bean AG, Roach DR, Briscoe H, France MP, Korner H, Sedgwick JD, Britton WJ. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection which is not compensated for by lymphotoxin. J Immunol 1999; 162:3504-11.
34. Myers Caruso A, Serbina N, Klein E, Triebold KJ, Bloom BR, Flynn JL. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-γ, yet succumb to tuberculosis. J Immunol 1999; 162:5407-16.
35. Scanga CA, Mohan VP, Yu K, Joseph H, Tanaka K, Chan J, Flynn JL. Depletion of CD4+ T cells causes reactivation of murine persistent tuberculosis despite continued expression of Interferon γ and Nitric oxide synthase 2. J Exp Med 2000; 192:347-58.
36. Jones BE, Young SM, Antoniskis D, Davidson PT, Kramer M, Barnes PF. Relationship of the manifestations of tuberculosis to CD4 counts in patients with human immunodeficiency virus infection. Am Rev Resp Dis 1993; 148:1292-7.
37. Tan JS, Canaday DH, Boom WH, Balaji KN, Schwander SK, Rich EA. Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: role for CD4+ and CD8+ cytotoxic T cells and relative resistance of alveolar macrophages to lysis. J Immunol 2000; 159:290-7.
38. Oddo M, Renno T, Attinger A, Bakker T, Macdonald HR, Meylan PR. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J Immunol 1998; 160:5448-54.
39. Stenger S, Mazzaccaro RJ, Uyemura K, et al. Differential effects of cytolytic T cell subsets in intracellular infection. Science 1997; 276:1684-7.
40. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1992; 89:12013-7.
41. Behar SM, Dascher CC, Grusby MJ, Wang CR, Brenner MB. Susceptibility of mice deficient on CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med 1999; 189:1973-80.
42. Cooper AM, D'Souza C, Frank AA, Orme IM. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin or granzyme mediated cytolytic mechanisms. Infect Immun 1997; 65:1317-20.
43. Sousa AO, Mazzaccaro RJ, Russell RG, Lee FK, Turner OC, Hong S, Van Kaer L, Bloom BR. Relative contributions of distinct MHC class 1-dependent cell populations in protection to tuberculosis infection in mice. Proc Natl Acad Sci USA 1999; 97:4204-8.
44. Perarnau B, Saron M-F, Reina San Martin B, Bervas N, et al. Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+ T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses. Eur J Immunol 1999; 29:1243-52.
45. Levy JE, Montross LK, Andrews NC. Genes that modify the hemachromatosis phenotype in mice. J Clin Invest 2000; 105:1209-16.
46. Mazzaccaro RJ, Stenger S, Rock KL, Porcelli SA, Brenner MB, Bloom BR. Cytotoxic T lymphocytes in resistance to tuberculosis. Adv Exp Med Biol 1998; 452:85-101.
47. Yrlid U, Wick MJ. Salmonella-induced apoptosis of infected macrophages results in presentation of bacteria encoded antigen after uptake by bystander dendritic cells. J Exp Med 2000; 191:624-30.
48. Fayyazi A, Eichmeyer B, Soruri A, Schweyer S, Herms J, Schwarz P, Radzun HJ. Apoptosis of macrophages and T cells in tuberculosis associated caseous necrosis. J Pathol 2000; 191:417-25.
49. Burdin N, Kronenberg M. CD1-mediated immune responses to glycolipids. Curr Opin Immunol 1999; 11:326-31.
50. Porcelli SA, Modlin RL. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol 1999; 17:297-329.
51. Schaible UE, Kaufmann SHE. CD1 and CD1-restricted T cells in infections with intracellular bacteria. Trends Microbiol 2000; 8:419-25.
52. Schaible UE, Hagens K, Fischer K. Collins HL, Kaufmann SHE. Intersection of group I CD1 molecules and mycobacteria in different intracellular compartments of dendritic cells. J Immunol 2000; 164:4843-52.
53. Sugita M, van der Wel N, Rogers RA, Peters P, Brenner MB. CD1c molecules broadly survey the endocytic system. Proc Natl Acad Sci USA 2000; 97:8445-50.
54. Schaible UE, Sturgill-Koszycki S, Schlesinger PH, Russell DG, Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J Immunol 1998; 160:1290-6.
55. Beatty WL, Rhoades E, Ullrich HJ, Chatterjee D, Heuser JE, Russell DG. Trafficking and release of mycobacterial lipids from infected macrophages. Traffick 2000; 1:235-47.
56. Kawano T, Cui J, Koezuka Y, et al. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 1997; 278:1626-9.
57. Soloski MJ, Szperka ME, Davies A. Wooden SL. Host immune response to intracellular bacteria: a role for MHC-linked class-Ib antigen-presenting molecules. Proc Soc Exp Biol Med 2000; 224:231-9.
58. Dow SW, Roberts A, Vyas J, Rodgers J, Rich RR, Orme IM, Potter TA. Immunization with f-Met peptides induces immune reactivity against Mycobacterium tuberculosis. Tuber Lung Dis 2000; 80:5-13.
59. Pathan AA, Wilkinson KA, Wilkinson RJ, Latif M, McShane H, Pasvol G, Lalvani A. High frequencies of circulating IFN-γ secreting CD8 cytotoxic T cells specific for a novel MHC-class I restricted Mycobacterium tuberculosis epitope in M. tuberculosis infected subjects without disease. Eur J Immunol 2000; 30:2713-21.
60. Laochumroonvorapong P, Wang J, Liu CC, Ye W, Moreira AL, Elkon KB, Freedman VH, Kaplan G. Perform, a cytotoxic molecule which mediated cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect Immun 1997; 65:127-32.
61. Serbina NV, Liu CC, Scanga CA, Flynn JL. CD8+ CTL from lungs of Mycobacterium tuberculosis infected mice express perforin in vivo and lyse infected macrophages. J Immunol 2000; 165:353-63.
62. Stenger S, Hanson DA, Teitelbaum R, et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998; 282:121-5.
63. Matloubian M, Suresh M, Glass A, et al. A role for perforin in downregulating T-cell responses during chronic viral infection. J Virol 1999; 73:2527-36.
64. Modlin RL, Pirmez C, Hofman FM, Torigian V, Uyemura K, Rea TH, Bloom BR, Brenner MB. Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions. Nature 1989; 339:544-8.
65. Griffin JP, Harshan KV, Born WK, Orme IM. Kinetics of accumulation of gamma delta receptor bearing T lymphocytes in mice infected with live mycobacteria. Infect Immun 1991; 59:4263-5.
66. Kaufmann SHE. Gamma/delta and other unconventional T lymphocytes: what do they see and what do they do? Proc Natl Acad Sci USA 1996; 93:2272-9.
67. D, Souza C, Cooper AM, Frank AA, Mazzaccaro RJ, Bloom BR, Orme IM. An anti-inflammatory role for γδ T lymphocytes in acquired immunity to Mycobacterium tuberculosis. J Immunol 1997; 158:1217-21.
68. Ladel CH, Blum C, Dreher A, Reifenberg K, Kaufmann SH, Protective role of gamma/delta T cells and alpha/beta T cells in tuberculosis. Eur J Immunol 1995; 25:2877-81.
69. Li B, Rossman MD, Imir T, Oner-Eyuboglu AF, Lee CW, Biancaniello R, Carding SR. Disease specific changes in gamma delta T cell repertoire and function in patients with pulmonary tuberculosis. J Immunol 1996; 157:4222-9.
70. Behr-Perst SI, Munk ME, Schaberg T, Ulrichs T, Schulz RJ, Kaufmann SHE. Phenotypically activated gamma delta T lymphocytes in the peripheral blood of patients with tuberculosis. J Infect Dis 1999; 180:141-9.
71. Dieli F, Troye-Blomberg M, Ivanyi I, Fournie JJ, Bonneville M, Peyrat MA, Sireci G. Salerno A. Vγ9/Vδ2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis. Eur J Immunol 2000; 30:1512-19.
72. Li B, Bassiri H, Rossman MD, et al. Involvement of the Fas/Fas ligand pathway in activation induced death of mycobacteria reactive human γδ T cells: a mechanism for the loss of γδ T cells in patients with pulmonary tuberculosis. J Immunol 1998; 161:1558-67.
73. Manfredi AA, Heltai S, Rovere P, et al. Mycobacterium tuberculosis exploits the CD95 /CD95 ligand system of γδ T cells to cause apoptosis. Eur J Immunol 1998; 28:1798-806.
74. Kaufmann SHE. Is the development of a new tuberculosis vaccine possible? Nat Med 2000; 6:955-60.
75. van Rie A, Warren R, Richardson M, Victor TC, Gie RP, Enarson DA, Beyers N, van Helden P. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 1999; 341:1174-9.
76. Cole ST, Brosch R, Parkhill J, et al. Deciphering the biology of Mycobacterium tuberculasis from the complete genome sequence. Nature 1998; 393:537-14.
77. 2 microglobulin-dependent resistance to Mycobacterium tuberculosis. Eur J Imrnunol 2001; in press.